Episode 267: PREMIUM – Guidelines, blood pressure and antiplatelets
In episode 267, James and Mike finally get to the first PREMIUM podcast of 2015 – and boy is it something. We discuss a new paper put out by the Edmonton gang on who actually contributes to primary care guidelines, we talk about a new systematic review of mild hypertension treatment, and finally discuss a NEJM article on the duration of dual antiplatelets. At the end we both agree this podcast was really something.
1) Contributors to primary care guidelines
Can Fam Physician 2015;61:52-8
2) Effects of Blood Pressure Reduction in Mild Hypertension
A Systematic Review and Meta-analysis
Ann Intern Med. 2015;162(3):184-191. doi:10.7326/M14-0773
3) Twelve or 30 Months of Dual Antiplatelet Therapy after Drug-Eluting Stents
Listening to this episode is for premium podcast members only. If you already have a membership, login to your account. If you aren't yet a premium subscriber, sign up today!